Graduate Interdisciplinary Program in Neuroscience, University of Arizona, Tucson, United States.
Department of Neuroscience, University of Arizona, Tucson, United States.
Elife. 2019 Oct 30;8:e46607. doi: 10.7554/eLife.46607.
The autosomal dominant neuronal ceroid lipofuscinoses (NCL) is caused by mutations in the synaptic vesicle (SV) protein CSPα. We developed animal models of by expressing mutant human CSPα (hCSPα) in neurons. Similar to patients, mutations induced excessive oligomerization of hCSPα and premature lethality in a dose-dependent manner. Instead of being localized to SVs, most mutant hCSPα accumulated abnormally, and co-localized with ubiquitinated proteins and the prelysosomal markers HRS and LAMP1. Ultrastructural examination revealed frequent abnormal membrane structures in axons and neuronal somata. The lethality, oligomerization and prelysosomal accumulation induced by mutations was attenuated by reducing endogenous wild type (WT) dCSP levels and enhanced by increasing WT levels. Furthermore, reducing the gene dosage of Hsc70 also attenuated phenotypes. Taken together, we suggest that alleles resemble dominant hypermorphic gain of function mutations that drive excessive oligomerization and impair membrane trafficking.
常染色体显性神经元蜡样脂褐质沉积症(NCL)是由突触囊泡(SV)蛋白 CSPα 的突变引起的。我们通过在神经元中表达突变的人 CSPα(hCSPα)来开发该疾病的动物模型。与患者相似,突变以剂量依赖性方式诱导 hCSPα 的过度寡聚化和过早致死。大多数突变的 hCSPα 没有定位到 SV 上,而是异常积累,并与泛素化蛋白和溶酶体前标记物 HRS 和 LAMP1 共定位。超微结构检查显示轴突和神经元胞体中经常出现异常的膜结构。通过降低内源性野生型(WT)dCSP 水平,可以减弱 突变引起的致死性、寡聚化和溶酶体前积累,而通过增加 WT 水平则可以增强这些作用。此外,降低 Hsc70 的基因剂量也可以减弱 表型。总之,我们认为 等位基因类似于显性超活力获得性功能突变,这些突变会导致过度寡聚化并损害膜运输。